S 2513 · 119th CongressIn Committeecongress.gov ↗

OTC Monograph Drug User Fee Transparency Act

What this bill does

AI plain-language summary

This bill appears to deal with fees that companies pay to the government related to over-the-counter (OTC) monograph drugs, which are common non-prescription medicines like pain relievers or cold medicines. It seems to focus on making the process for collecting or using those fees more transparent and open to the public. No official summary is available for this bill.

Introduced

July 29, 2025

Policy Area

Health

Your Vote

Discussion (0)

Explain what is at stake in this bill.

Sign in to join the discussion.

No comments yet. Be the first.